PMID: 2120512Aug 1, 1990Paper

Interferon as treatment for viral hepatitis: a progress report

The Journal of the South Carolina Medical Association
W M Lee

Abstract

Treatment of chronic hepatitis with interferon is in its infancy and it is likely that information that we learn today will markedly improve the treatment that is offered tomorrow. The limitations of interferon treatment at the present time are the lack of complete predictable responses in approximately half the patients and the relatively high relapse rates observed thus far. It is predicted that higher doses will result in better response and lower relapse rates, but this remains to be seen. The cost and the frequency of side effects will likely be significantly increased by escalation of dose, but the chance of eradicating an otherwise untreatable and not benign condition is tempting and will continue to challenge our best efforts.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Oncology : a Journal of the Royal College of Radiologists
N G BurnetJ H Peacock
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
F Randy VogenbergVincent DeSantis
BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
G PizzarelliS Musumeci
© 2021 Meta ULC. All rights reserved